<?xml version='1.0' encoding='utf-8'?>
<document id="22039788"><sentence text="Macrocyclic lactones and cellular transport-related drug interactions: a perspective from in vitro assays to nematode control in the field."><entity charOffset="0-20" id="DDI-PubMed.22039788.s1.e0" text="Macrocyclic lactones" /></sentence><sentence text="Macrocyclic lactones (MLs) are antiparasitic drugs used against endo-ectoparasites"><entity charOffset="0-20" id="DDI-PubMed.22039788.s2.e0" text="Macrocyclic lactones" /><entity charOffset="22-25" id="DDI-PubMed.22039788.s2.e1" text="MLs" /><pair ddi="false" e1="DDI-PubMed.22039788.s2.e0" e2="DDI-PubMed.22039788.s2.e0" /><pair ddi="false" e1="DDI-PubMed.22039788.s2.e0" e2="DDI-PubMed.22039788.s2.e1" /></sentence><sentence text=" Regarding the wide use of MLs in different species, it is likely that drug-drug interactions may occur after their co-administration with other compounds"><entity charOffset="27-29" id="DDI-PubMed.22039788.s3.e0" text="MLs" /></sentence><sentence text=" A new paradigm was introduced in the study of the pharmacology of MLs during the last years since the interactions of MLs with ATP-binding cassete (ABC) transporters have been described"><entity charOffset="67-69" id="DDI-PubMed.22039788.s4.e0" text="MLs" /><entity charOffset="119-121" id="DDI-PubMed.22039788.s4.e1" text="MLs" /><pair ddi="false" e1="DDI-PubMed.22039788.s4.e0" e2="DDI-PubMed.22039788.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22039788.s4.e0" e2="DDI-PubMed.22039788.s4.e1" /></sentence><sentence text=" The current review article gives an update on the available information concerning drug-drug interactions involving the MLs"><entity charOffset="121-123" id="DDI-PubMed.22039788.s5.e0" text="MLs" /></sentence><sentence text=" The basis of the methodological approaches used to evaluate transport interactions, and the impact of the pharmacology-based modulation of drug transport on the MLs disposition kinetics and clinical efficacy, are discussed in an integrated manner"><entity charOffset="162-164" id="DDI-PubMed.22039788.s6.e0" text="MLs" /></sentence><sentence text=" A different number of in vitro and ex vivo methods have been reported to study the characterization of the interactions between MLs and ABC transporters"><entity charOffset="129-131" id="DDI-PubMed.22039788.s7.e0" text="MLs" /></sentence><sentence text=" The production of the ABC transporters knockout mice has provided valuable in vivo tools to study this type of drug-drug interaction" /><sentence text=" In vivo trials performed in different species corroborated the effects of ABC transporter modulators on the pharmacokinetics behaviour of MLs"><entity charOffset="139-141" id="DDI-PubMed.22039788.s9.e0" text="MLs" /></sentence><sentence text=" Important pharmacokinetic changes on plasma disposition of MLs have been observed when these compounds are co-administered with P-glycoprotein modulators"><entity charOffset="60-62" id="DDI-PubMed.22039788.s10.e0" text="MLs" /></sentence><sentence text=" The modulation of the activity of P-glycoprotein was evaluated as a strategy not only to increase the systemic availability of MLs but also to improve their clinical efficacy"><entity charOffset="128-130" id="DDI-PubMed.22039788.s11.e0" text="MLs" /></sentence><sentence text=" The understanding of the MLs interactions may supply relevant information to optimize their use in veterinary and human therapeutics"><entity charOffset="26-28" id="DDI-PubMed.22039788.s12.e0" text="MLs" /></sentence><sentence text="" /></document>